Skip to content

A cohort study on precision management of gestational diabetes mellitus based on big data

A cohort study on precision management of gestational diabetes mellitus based on big data

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400092624
Enrollment
Unknown
Registered
2024-11-20
Start date
2024-11-25
Completion date
Unknown
Last updated
2024-12-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gestational diabetes mellitus

Interventions

GDM group:personalized diet and exercise intervention
Control group:N/A

Sponsors

Jiangsu Province Hospital (The First Affiliated Hospital with Nanjing Medical University)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1.Age between 18 and 40 years; 2.Pre-pregnancy BMI between 18.5 kg/m^2 and 28 kg/m^2; 3.Ability to read, understand, and sign the informed consent form; 4.The pregnant woman receives prenatal care and delivers at the study hospital.

Exclusion criteria

Exclusion criteria: 1.Twin or multiple pregnancies; 2.Pre-existing diabetes mellitus (PGDM), including gestational diabetes diagnosed during pregnancy (fasting blood glucose >=7.0 mmol/L or OGTT 2-hour blood glucose >= 11.1 mmol/L); 3.Poorly controlled pre-existing chronic hypertension (blood pressure >= 140/90 mmHg); 4.Coexisting severe liver or kidney disease (alanine aminotransferase greater than 2.5 times the upper limit of normal, creatinine greater than 132 mmol/L); 5.Current or recent use of medications affecting glucose metabolism, including steroids, hydroxyprogesterone caproate, antiretroviral drugs, etc.; 6.Mental disorders and severe psychological conditions (measured using scales: PHQ-9 for depression and GAD-7 for anxiety); 7.Coexisting severe infections; 8.Inability to adequately understand the requirements of the project, poor compliance, refusal to use continuous glucose monitoring (CGM) or to perform self-monitored blood glucose (SMBG) tests as required.

Design outcomes

Primary

MeasureTime frame
Adverse Pregnancy Outcomes Occurrence;Long-Term Incidence of Type 2 Diabetes Mellitus;Long-Term Incidence of Cardiovascular Disease (CVD);

Countries

China

Contacts

Public ContactYun Liu

Jiangsu Provincial People's Hospital (The First Affiliated Hospital of Nanjing Medical University)

liuyun@njmu.edu.cn+86 25 68306538

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026